Москва, 15 октября 2014 - Компания GE Healthcare представила свою экспертизу и готовность к сотрудничеству в области создания новых и модернизации существующих медицинских учреждений. Серия мастер-классов для администраторов здравоохранения, а также для руководителей и менеджеров клиник прошла в рамках 2-й международной выставки и конгресса «Медицинские учреждения в России: проектирование, строительство, оснащение и управление» 13-15 октября 2014 года.
CHALFONT ST GILES, UK - 3 October 2014 - GE Healthcare Life Sciences (NYSE:GE) announced today that the company has been shortlisted as a finalist for four BioProcess International (BPI) Awards1. These prestigious awards, which are voted for by experts in the field and supported by bioprocess specialist publication BioProcess International - celebrate and recognize the outstanding people, organizations and technologies that have significantly
Allegheny, PA, October 1, 2014 - Allegheny Health Network is the first center in the nation to install SenoClaire*, GE Healthcare’s (NYSE: GE) new breast tomosynthesis solution designed with a three-dimensional imaging technology. SenoClaire, which was approved by the FDA earlier this month, uses a low-dose short X-ray sweep around the positioned breast with nine exposures acquired with a “step-and-shoot” method, removing the potential motion from the tube helping to reduce blur and increase image sharpness.
Aliso Viejo, CA - September 30, 2014 - GE Healthcare today announced an agreement between its affiliate, Clarient Diagnostic Services, Inc. (Clarient) and GlaxoSmithKline (GSK). The collaboration aims to improve access to diagnostic testing for cancer patients by establishing a network of clinical laboratories to identify genetic mutations associated with different tumour types. The collaboration will enable GE to develop a broader laboratory and data analytics service that will enable better efficiency in the healthcare market related to oncology precision medicine.
